Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Renal Allograft Recipients: later-stage trial registry

1 of 1 indexed Renal Allograft Recipients trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Renal Allograft Recipients: 1 US clinical trial tracked, 1 recruiting.

Renal Allograft Recipients is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Bristol-Myers Squibb, running 1 of these trials.

Enrollment posture brief

Registry condition renal-allograft-recipients

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Renal Allograft Recipien (this)Renal Allograft Recipien (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Renal Allograft Recipients

Renal Allograft Recipients lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Renal Allograft Recipients on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Renal Allograft Recipients is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Renal Allograft Recipients records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Enteric Coated Mycophenolate Sodium Drug
1 trials
Belatacept Biological
1 trials
Cyclosporine A Drug
1 trials
Tacrolimus Drug
1 trials
Mycophenolate Mofetil Drug
1 trials

US sites by state

Facility locations filed on Renal Allograft Recipients trials. A trial with sites in several states counts in each.

Washington 1 trials
Oregon 1 trials
Ohio 1 trials
North Carolina 1 trials
Missouri 1 trials
Maryland 1 trials
Massachusetts 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Renal Allograft Recipients page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Renal Allograft Recipients trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Bristol-Myers Squibb sponsors the most Renal Allograft Recipients trials on record, review their full trial history before evaluating a specific study. See Bristol-Myers Squibb's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Allograft Recipients condition card totals 1 registered trials; most-linked intervention Enteric Coated Mycophenolate Sodium; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.